The CCES Completes Testing of Team Canada Prior to Tokyo 2020 Paralympics

(Ottawa, Ontario – August 25, 2021) – The Canadian Centre for Ethics in Sport (CCES) has successfully completed its pre-Games testing program prior to the 2020 Paralympic Games in Tokyo. We would like to wish all members of Team Canada good luck and we hope the Games are a safe and healthy experience for everyone.  

“The CCES has fulfilled its commitment to the Canadian Paralympic Committee (CPC) and the athletes who will compete for Canada at the Paralympic Games,” said Paul Melia, President and CEO of the CCES. “The testing program was comprehensive, intelligence-based, and incorporated a thorough sport-specific risk assessment.”

In addition to pre-Games testing, the CCES made anti-doping information and resources available to athletes and support personnel. All athletes were provided with the CCES's True Sport Clean online learning course within the last year; a comprehensive course that ensures athletes who are subject to doping control understand their rights and responsibilities.

“Thank you to our partners in the sport community who helped us reach our testing goals and protect irreplaceable Paralympic moments,” said Mr. Melia. “We encourage Team Canada to live their values and to embrace the True Sport Principles that represent the good sport Canadians believe in. Good luck to you in Tokyo!”

About the CCES

The CCES is an independent, national, not-for profit organization with a responsibility to administer the Canadian Anti-Doping Program. We recognize that true sport can make a great difference for individuals, communities and our country. The CCES acknowledges funding, in part, from the Government of Canada. We are committed to making sport better by working collaboratively to activate a values-based and principle-driven sport system; protecting the integrity of sport from the negative forces of doping and other unethical threats; and advocating for sport that is fair, safe and open to everyone.

-- 30 --

For further information, please contact:

+1 613-521-3340 x3233
[email protected]